1. Home
  2. CRNX vs CHSCL Comparison

CRNX vs CHSCL Comparison

Compare CRNX & CHSCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Crinetics Pharmaceuticals Inc.

CRNX

Crinetics Pharmaceuticals Inc.

HOLD

Current Price

$50.53

Market Cap

4.1B

Sector

Health Care

ML Signal

HOLD

Logo CHS Inc

CHSCL

CHS Inc

HOLD

Current Price

$25.75

Market Cap

0.0

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRNX
CHSCL
Founded
2008
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Farming/Seeds/Milling
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
4.1B
N/A
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
CRNX
CHSCL
Price
$50.53
$25.75
Analyst Decision
Buy
Analyst Count
11
0
Target Price
$71.00
N/A
AVG Volume (30 Days)
1.1M
N/A
Earning Date
11-06-2025
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,535,000.00
N/A
Revenue This Year
$425.31
N/A
Revenue Next Year
$943.50
N/A
P/E Ratio
N/A
N/A
Revenue Growth
47.74
N/A
52 Week Low
$24.10
N/A
52 Week High
$60.25
N/A

Technical Indicators

Market Signals
Indicator
CRNX
CHSCL
Relative Strength Index (RSI) 72.28 64.82
Support Level $46.49 $25.67
Resistance Level $49.29 $25.74
Average True Range (ATR) 1.96 0.08
MACD 0.41 0.02
Stochastic Oscillator 94.31 94.25

Price Performance

Historical Comparison
CRNX
CHSCL

About CRNX Crinetics Pharmaceuticals Inc.

Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.

About CHSCL CHS Inc

CHS Inc is an integrated agricultural enterprise, that provides grain, food, and energy resources to businesses and consumers. Its Energy segment produces and provides wholesale distribution of petroleum products and transportation of those products. Its Ag segment, which is the key revenue driver, purchases and processes or resells grains and oilseeds; serves as a wholesaler and retailer of crop inputs; produces and markets ethanol. Its Nitrogen Production segment consists of equity method investment in CF Nitrogen, which entitles the purchase of up to a specified quantity of granular urea and UAN annually from CF Nitrogen. Geographically, the company derives maximum revenue from North America and the rest from South America, Asia Pacific, Europe, Middle East, and Africa (EMEA).

Share on Social Networks: